. 'I'he acclinratization time l'or both devices rvas quite long (.1 to 6 weeks) rvhich could have Ied to the withdrarval of subjects who could not tolerate either or both the therapies prior to the actual start ofthe treatlnent phase (despite argunlents by the authors to the contrar]).'l'his could make therapy aoceptance and adherence appear to be better than rvould have otherwise been the case.
I0Ufnal L, iLIllllel1l $tieo meAilin; I http:/idx.doi.org/1 0.56Mijcsm.300B rcldtcd tu Sleep ltedi<:inefiom a nunber ofjcturnals. lt is'a recurringfeature ofthe ,lotu'nal. l'he editorial sntfl re gularl y-assesse s n ett lt-publ ished ntedico I I it erafi rre reloteLl to Sleep lvtedicine andfeulures pcrpers thut are important.fbr Sleep . 'I'he acclinratization time l'or both devices rvas quite long (.1 to 6 weeks) rvhich could have Ied to the withdrarval of subjects who could not tolerate either or both the therapies prior to the actual start ofthe treatlnent phase (despite argunlents by the authors to the contrar]).'l'his could make therapy aoceptance and adherence appear to be better than rvould have otherwise been the case.
In our opinion, none of these potential problems importantly aff'ected lhe outcome of this study which is clearly the best to date addressins the question raised (outcorrres of CPAP versus MAD therapy in obsructive sleep apnea).
Should the guideline regarding the use of MADs in the therapy of severe 0SA be changed? 'fhus the question is how'well did these patients fare on the MAD device? The mean AHI for this group was 42 otf therapy ;il,;;--;';;;'',orri'0"," are a bit ditficutt to ascerta*r riorn ttre paper, Figure 2 
